Natixis Advisors LLC reduced its position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 0.7% during the 3rd ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. Shares of ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Globus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

The company currently has its sales operations distributed across 51 counties worldwide. GMED boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating.

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this ...

Furthermore, we provide coverage of situations and names on request! Analyst’s Disclosure: I/we have a beneficial long position in the shares of GMED either through stock ownership, options, or other ...

Globus Medical (GMED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of B thanks ...

JMP Securities analyst David Turkaly has reiterated their neutral stance on GMED stock, giving a Hold rating on November 11. David Turkaly has ...